Skip to main content

End of the COVID Public Health Emergency: What This Means for FDA-Regulated Companies and Next Steps

In this webinar, Justin Prochnow and Nancy Taylor will cover upcoming regulatory and business changes associated with the end of the COVID-19 public health emergency (PHE) which is currently scheduled to take place on May 11, 2023. They will discuss the changes and impacts on FDA regulated entities, including:

  • Waivers within the FDA that are impacted and affect each FDA center, including the following key issues:

            o Changes to food labeling and other food related issues

            o Changes to certain Emergency Use Authorizations (EUA) for drugs,

                vaccines and testing and other COVID-19 related issues

  • Lessons learned by the FDA and HHS for future pandemics

This webinar is part one of a two-part series on the end of the COVID-19 Public Health Emergency Transition. 

1.0 General Hour CLE credit pending approval in: AZ, CA, CO, FL, GA, IL, NJ, NV, PA & TX.
1.0 Transitional Professional Practice credit pending for NY.
DE, OR, MN, NC, UT & VA CLE credit will be sought upon request.

Contact Martin Brogan at with questions.